301 related articles for article (PubMed ID: 29933890)
1. Amyotrophic lateral sclerosis: The complement and inflammatory hypothesis.
Kjældgaard AL; Pilely K; Olsen KS; Pedersen SW; Lauritsen AØ; Møller K; Garred P
Mol Immunol; 2018 Oct; 102():14-25. PubMed ID: 29933890
[TBL] [Abstract][Full Text] [Related]
2. Revisiting the role of the innate immune complement system in ALS.
Parker SE; Hanton AM; Stefanou SN; Noakes PG; Woodruff TM; Lee JD
Neurobiol Dis; 2019 Jul; 127():223-232. PubMed ID: 30849511
[TBL] [Abstract][Full Text] [Related]
3. The potential interplay between energy metabolism and innate complement activation in amyotrophic lateral sclerosis.
McDonald TS; McCombe PA; Woodruff TM; Lee JD
FASEB J; 2020 Jun; 34(6):7225-7233. PubMed ID: 32307753
[TBL] [Abstract][Full Text] [Related]
4. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.
Sta M; Sylva-Steenland RM; Casula M; de Jong JM; Troost D; Aronica E; Baas F
Neurobiol Dis; 2011 Jun; 42(3):211-20. PubMed ID: 21220013
[TBL] [Abstract][Full Text] [Related]
5. Complement activation at the motor end-plates in amyotrophic lateral sclerosis.
Bahia El Idrissi N; Bosch S; Ramaglia V; Aronica E; Baas F; Troost D
J Neuroinflammation; 2016 Apr; 13(1):72. PubMed ID: 27056040
[TBL] [Abstract][Full Text] [Related]
6. Innate immunity in amyotrophic lateral sclerosis.
Moisse K; Strong MJ
Biochim Biophys Acta; 2006; 1762(11-12):1083-93. PubMed ID: 16624536
[TBL] [Abstract][Full Text] [Related]
7. Neuroimmunity in amyotrophic lateral sclerosis: focus on microglia.
Motataianu A; Barcutean L; Balasa R
Amyotroph Lateral Scler Frontotemporal Degener; 2020 May; 21(3-4):159-166. PubMed ID: 31903792
[TBL] [Abstract][Full Text] [Related]
8. Disease origin and progression in amyotrophic lateral sclerosis: an immunology perspective.
Malaspina A; Puentes F; Amor S
Int Immunol; 2015 Mar; 27(3):117-29. PubMed ID: 25344935
[TBL] [Abstract][Full Text] [Related]
9. Temporospatial Analysis and New Players in the Immunology of Amyotrophic Lateral Sclerosis.
Iyer AK; Jones KJ; Sanders VM; Walker CL
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473876
[TBL] [Abstract][Full Text] [Related]
10. The dual roles of immunity in ALS: injury overrides protection.
Murdock BJ; Bender DE; Segal BM; Feldman EL
Neurobiol Dis; 2015 May; 77():1-12. PubMed ID: 25726748
[TBL] [Abstract][Full Text] [Related]
11. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
12. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
Cervetto C; Frattaroli D; Maura G; Marcoli M
Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
[TBL] [Abstract][Full Text] [Related]
13. Immune system alterations in amyotrophic lateral sclerosis.
Hovden H; Frederiksen JL; Pedersen SW
Acta Neurol Scand; 2013 Nov; 128(5):287-96. PubMed ID: 23550891
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.
Zhao W; Beers DR; Appel SH
J Neuroimmune Pharmacol; 2013 Sep; 8(4):888-99. PubMed ID: 23881705
[TBL] [Abstract][Full Text] [Related]
15. The Emerging Role of the Major Histocompatibility Complex Class I in Amyotrophic Lateral Sclerosis.
Chiarotto GB; Nardo G; Trolese MC; França MC; Bendotti C; Rodrigues de Oliveira AL
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104236
[TBL] [Abstract][Full Text] [Related]
16. Involvement of immune response in the pathogenesis of amyotrophic lateral sclerosis: a therapeutic opportunity?
Calvo A; Moglia C; Balma M; Chiò A
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):325-30. PubMed ID: 20406178
[TBL] [Abstract][Full Text] [Related]
17. Complement Profiles in Patients with Amyotrophic Lateral Sclerosis: A Prospective Observational Cohort Study.
Kjældgaard AL; Pilely K; Olsen KS; Øberg Lauritsen A; Wørlich Pedersen S; Svenstrup K; Karlsborg M; Thagesen H; Blaabjerg M; Theódórsdóttir Á; Gundtoft Elmo E; Torvin Møller A; Pedersen NA; Kirkegaard N; Møller K; Garred P
J Inflamm Res; 2021; 14():1043-1053. PubMed ID: 33790619
[TBL] [Abstract][Full Text] [Related]
18. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
19. The 'Omics' of Amyotrophic Lateral Sclerosis.
Caballero-Hernandez D; Toscano MG; Cejudo-Guillen M; Garcia-Martin ML; Lopez S; Franco JM; Quintana FJ; Roodveldt C; Pozo D
Trends Mol Med; 2016 Jan; 22(1):53-67. PubMed ID: 26691296
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an early innate immune response in the motor cortex of ALS.
Jara JH; Genç B; Stanford MJ; Pytel P; Roos RP; Weintraub S; Mesulam MM; Bigio EH; Miller RJ; Özdinler PH
J Neuroinflammation; 2017 Jun; 14(1):129. PubMed ID: 28651542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
